Overview
Weight loss results vary for every individual, but clinical trials give a clear picture of the potential outcomes when Mounjaro® or Wegovy®, available through MedExpress, are combined with lifestyle changes.
Use this article when you want to:
Compare average weight loss results between Mounjaro® and Wegovy®.
Understand the factors that influence your progress.
Set healthy, realistic weight loss goals.
What Weight Loss Results Have Clinical Trials Shown for Mounjaro® and Wegovy®?
Clinical studies have shown significant weight reduction over a period of 15 to 18 months:
Mounjaro® (tirzepatide): Patients lost up to 20.9% of their body weight after 72 weeks of treatment.
Wegovy® (semaglutide): Patients lost an average of 14.9% of their body weight after 68 weeks.
These figures represent averages found in clinical settings — while some people lost more, others lost less.
What Factors Influence My Weight Loss Success?
Mounjaro® and Wegovy® are powerful tools, but your individual results can also depend on several lifestyle factors:
Diet: Following a balanced, reduced-calorie nutrition plan.
Physical activity: Incorporating regular exercise into your weekly routine.
Consistency: Adhering strictly to your weekly MedExpress dosing schedule.
What Is a Realistic Weight Loss Expectation Each Week?
It's important to set healthy expectations based on your personal health goals. In the clinical community, it's generally recommended to aim for a steady weight loss of 1-2 lbs (0.5-1 kg) each week. This gradual pace is often more sustainable and better for your long-term health.